CDC Lists Dozens of Infectious Disease Tests as Unavailable in Lab Directory
Thirty-one test orders are currently listed as unavailable, requiring labs to seek alternative testing pathways or coordinate with public health partners.
Latest Articles
Editor's Top Picks
Ordering Both ESR and CRP Tests Could Save Hospitals Nearly $10 Million Per Year, Study Finds
A peer-reviewed economic analysis challenges the assumption that erythrocyte sedimentation rate and C-reactive protein tests are interchangeable, finding that combined testing reduces misdiagnoses and lowers overall costs.
Be the First to Know What’s Next in the Lab
Every week, we dig into the biggest shifts, breakthroughs, and tech transforming clinical diagnostics. Straightforward, insightful, and always relevant.Critical Resources
Diagnostic Innovations
Molecular Test Detects Bile Duct Cancer at Twice the Rate of Standard Methods
The BiliSeq molecular test detected bile duct cancer in 82% of cases—compared to 44% with standard pathology—according to a six-year, multi-institutional study.
Equipment & Supply Spotlight
Abbott, Flatiron Health Integrate Precision Oncology Tests Into Oncology EMR Platform
The integration gives more than 4,700 oncology providers across 1,600-plus community cancer care centers direct access to order and receive results from multiple precision oncology tests within a single clinical workflow.
News, Know-How & Standards
Disease Detection & Understanding
Blood Test May Improve Risk Assessment for HPV-Related Throat Cancer
Research identifies how circulating tumor DNA can inform personalized treatment and surveillance strategies.
